Search Results - Douget, Mickaël Le

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase

    Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the... by Guagnano, Vito, Furet, Pascal, Spanka, Carsten, Bordas, Vincent, Le Douget, Mickaël, Stamm, Christelle, Brueggen, Josef, Jensen, Michael R, Schnell, Christian, Schmid, Herbert, Wartmann, Markus, Berghausen, Joerg, Drueckes, Peter, Zimmerlin, Alfred, Bussiere, Dirksen, Murray, Jeremy, Graus Porta, Diana

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor

    FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor by Guagnano, Vito, Kauffmann, Audrey, Wöhrle, Simon, Stamm, Christelle, Ito, Moriko, Barys, Louise, Pornon, Astrid, Yao, Yao, Li, Fang, Zhang, Yun, Chen, Zhi, Wilson, Christopher J, Bordas, Vincent, Le Douget, Mickaël, Gaither, L Alex, Borawski, Jason, Monahan, John E, Venkatesan, Kavitha, Brümmendorf, Thomas, Thomas, David M, Garcia-Echeverria, Carlos, Hofmann, Francesco, Sellers, William R, Graus-Porta, Diana

    Published in Cancer discovery
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition

    The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition by Furet, Pascal, Bordas, Vincent, Le Douget, Mickaël, Salem, Bahaa, Mesrouze, Yannick, Imbach‐Weese, Patricia, Sellner, Holger, Voegtle, Markus, Soldermann, Nicolas, Chapeau, Emilie, Wartmann, Markus, Scheufler, Clemens, Fernandez, Cesar, Kallen, Joerg, Guagnano, Vito, Chène, Patrick, Schmelzle, Tobias

    Published in ChemMedChem
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Optimization of a Class of Dihydrobenzofurane Analogs toward Orally Efficacious YAP‐TEAD Protein‐Protein Interaction Inhibitors

    Optimization of a Class of Dihydrobenzofurane Analogs toward Orally Efficacious YAP‐TEAD Protein‐Protein Interaction Inhibitors by Sellner, Holger, Chapeau, Emilie, Furet, Pascal, Voegtle, Markus, Salem, Bahaa, Le Douget, Mickaël, Bordas, Vincent, Groell, Jean‐Marc, Le Goff, Anne‐Laure, Rouzet, Christine, Wietlisbach, Thomas, Zimmermann, Thomas, McKenna, Joseph, Brocklehurst, Cara E., Chène, Patrick, Wartmann, Markus, Scheufler, Clemens, Kallen, Joerg, Williams, Gareth, Harlfinger, Stephanie, Traebert, Martin, Dumotier, Bérengère M., Schmelzle, Tobias, Soldermann, Nicolas

    Published in ChemMedChem
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Front Cover: The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition (ChemMedChem 19/2022)

    Front Cover: The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition (ChemMedChem 19/2022) by Furet, Pascal, Bordas, Vincent, Le Douget, Mickaël, Salem, Bahaa, Mesrouze, Yannick, Imbach‐Weese, Patricia, Sellner, Holger, Voegtle, Markus, Soldermann, Nicolas, Chapeau, Emilie, Wartmann, Markus, Scheufler, Clemens, Fernandez, Cesar, Kallen, Joerg, Guagnano, Vito, Chène, Patrick, Schmelzle, Tobias

    Published in ChemMedChem
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract 854: Patient stratification strategies for NVP-BGJ398, a selective pan-FGFR inhibitor in phase I clinical trials

    Abstract 854: Patient stratification strategies for NVP-BGJ398, a selective pan-FGFR inhibitor in phase I clinical trials by Porta, Diana Graus, Guagnano, Vito, Stamm, Christelle, Woehrle, Simon, Kauffmann, Audrey, Yao, Yao, Brümmendorf, Thomas, Bordas, Vincent, Douget, Mickaël Le, Zhang, Yun, Chen, Zhi, Ito, Moriko, Li, Fang, Monahan, John, Gaither, Alex, Borawski, Jason, Wilson, Christopher J., Venkatesan, Kavitha, Hofmann, Francesco, Sellers, William

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Abstract B246: NVP-BGJ398: A potent and selective inhibitor of the fibroblast growth factor receptor family

    Abstract B246: NVP-BGJ398: A potent and selective inhibitor of the fibroblast growth factor receptor family by Guagnano, Vito, Porta, Diana Graus, Bordas, Vincent, Douget, Mickael Le, Stamm, Christelle, Furet, Pascal, Spanka, Carsten, Wartmann, Markus, Schmid, Herbert, Brueggen, Josef, Drueckes, Peter, Bussiere, Dirksen, Abrams, Tinya, Rendahl, Katherine, Bernard-Pierrot, Isabelle, Radvanyi, Francois

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Abstract C193: FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a novel orally bioavailable, selective, and potent FGFR inhibitor

    Abstract C193: FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a novel orally bioavailable, selective, and potent FGFR inhibitor by Porta, Diana Graus, Guagnano, Vito, Yao, Yao, Kauffmann, Audrey, Stamm, Christelle, Chen, Zhi, Zhang, Yun, Bordas, Vincent, Douget, Mickael Le, Ito, Moriko, Li, Fang, Monahan, John, Gaither, Alex, Borawski, Jason, Wilson, Christopher J., Venkatesan, Kavitha, Bruemmendorf, Thomas, Hofmann, Francesco, Sellers, William R.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: